Shorted
Peak Processing logo
PKP
Pharmaceuticals, Biotechnology & Life Sciences

Peak Processing

Short interest
0.50%
as of 2 July 2026
Reported shorts
6.7M
Shares on issue
1.329B

Peak Processing (PKP) company profile

Profile, insiders and operations

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2026-09-25B Katzman
buy
---
2026-07-27B Katzman
buy
---
2026-07-24Barry Katzman
buy
5,650,000$0.028$158,200
2026-07-01M Adams
buy
---
2026-07-01M Pujara
buy
---
2026-07-01Barry Katzman
exercise options
1,128,316--
2026-06-30Matt Adams
buy
300,000$0.017$5,100
2026-06-29Manik Pujara
other
8,000,000$0.017$136,000
2026-05-07M Pujara
buy
---
2026-05-04Manik Pujara
buy
2,000,000$0.018$36,198
2026-03-25M Pujara
buy
---
2026-03-23Manik Pujara
buy
3,400,000$0.017$57,800
2025-12-16M Pujara
buy
---
2025-12-16M Adams
buy
---
2025-12-15Matt Adams
other
7,000,000$0.006$45,500
2025-12-15Manik Pujara
other
6,000,000$0.006$39,000
2025-04-30V Webber
buy
---
2025-04-30J Fegan
buy
---
2025-04-30M Adams
buy
---
2025-04-29Vaughan Webber
other
1,000,000$0.020$20,000

PKP intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required